BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28074063)

  • 1. Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.
    Herndon TM; Chen SS; Saba NS; Valdez J; Emson C; Gatmaitan M; Tian X; Hughes TE; Sun C; Arthur DC; Stetler-Stevenson M; Yuan CM; Niemann CU; Marti GE; Aue G; Soto S; Farooqui MZH; Herman SEM; Chiorazzi N; Wiestner A
    Leukemia; 2017 Jun; 31(6):1340-1347. PubMed ID: 28074063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
    Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
    Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Asplund SL; McKenna RW; Howard MS; Kroft SH
    Am J Surg Pathol; 2002 May; 26(5):624-9. PubMed ID: 11979092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.
    Wang L; Xu M; Wang C; Zhu L; Hu J; Chen S; Wu X; Li B; Li Y
    J Immunol Res; 2014; 2014():241246. PubMed ID: 24963496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments--peripheral blood, bone marrow and lymph node.
    Nadkarni JJ; Perambakam SM; Rathore VB; Amin KM; Parikh PM; Naresh KN; Advani SH
    Cancer Biother Radiopharm; 1998 Aug; 13(4):269-74. PubMed ID: 10850362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
    Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
    Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
    Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
    Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples.
    Xu Y; McKenna RW; Asplund SL; Kroft SH
    Am J Clin Pathol; 2002 Nov; 118(5):758-64. PubMed ID: 12428797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
    Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
    Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
    Hayden RE; Pratt G; Roberts C; Drayson MT; Bunce CM
    Leuk Lymphoma; 2012 Apr; 53(4):537-49. PubMed ID: 21812539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
    Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
    Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
    Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
    Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
    Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
    Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells.
    Bueso-Ramos CE; Ferrajoli A; Medeiros LJ; Keating MJ; Estrov Z
    Hematology; 2004 Aug; 9(4):279-86. PubMed ID: 15621735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
    Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
    Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restriction of blood and marrow CLL-B cells to free L-chain Ig secretion: implication for normal B-cell function and control.
    Hopper JE; O'Brien J; Papagiannes E
    Am J Hematol; 1988 Nov; 29(3):125-33. PubMed ID: 3142253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
    Gilling CE; Mittal AK; Chaturvedi NK; Iqbal J; Aoun P; Bierman PJ; Bociek RG; Weisenburger DD; Joshi SS
    Br J Haematol; 2012 Jul; 158(2):216-231. PubMed ID: 22571278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.